Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/2000
01/18/2000US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate
01/18/2000US6015708 Yeast artificial chromosome with mammalian dna including target gene and heterologous regulatory sequence; for expression in a mammalian cell and high yield of product with less manipulation
01/18/2000US6015702 Nucleotide and amino acid sequences; for diagnosis, prevention and treatment of neoplastic, developmental, immune and nervous system disorders; anticarcinogenic/antitumor/ antisense agents
01/18/2000US6015695 Immunoglobulins devoid of light chains
01/18/2000US6015694 Method for stimulating an immune response utilizing recombinant alphavirus particles
01/18/2000US6015688 Transferrin receptor genes
01/18/2000US6015687 Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof
01/18/2000US6015686 A eukaryotic promoter 5' of viral cdna which initiates within a cell the 5' to 3' synthesis of rna from complementary dna producing a vector construct which autonomously amplifies in a cell and expresses an heterologous sequence; gene therapy
01/18/2000US6015680 Human lung adenocarcinoma-related monoclonal antibody and immunoassay method which uses the same
01/18/2000US6015572 Glial cells with neurotropic factors for nerve damage
01/18/2000US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function
01/18/2000US6015556 Cytotoxic drug therapy
01/18/2000US6015542 Radioimmunotherapy of lymphoma using anti-CD20 antibodies
01/18/2000CA2132954C Modified ciliary neurotrophic factors
01/18/2000CA2087960C Endogenously sweetened transgenic plant products
01/18/2000CA2050336C Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
01/18/2000CA2013239C Yeast strains for the production of nature heterolegous proteins, especially hirudine, and corresponding process for the preparation of hirudine
01/18/2000CA2006587C Membrane proteins and peptides of haemophilus influenzae type b
01/18/2000CA1340877C Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
01/18/2000CA1340876C The vp7 gene of human rotavirus 4
01/14/2000CA2237704A1 Cleavage of caulobacter produced recombinant fusion proteins
01/13/2000WO2000001818A1 Human emr1-like g protein coupled receptor
01/13/2000WO2000001817A2 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
01/13/2000WO2000001815A2 Neurotrophic factors
01/13/2000WO2000001807A1 Serine protease-specific monoclonal antibody and utilization thereof
01/13/2000WO2000001728A1 Galectin 11
01/13/2000WO1999060135A8 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
01/13/2000WO1999053060A3 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
01/13/2000WO1999046286A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto
01/13/2000CA2336406A1 Galectin 11
01/13/2000CA2332573A1 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
01/13/2000CA2331394A1 Human emr1-like g protein coupled receptor
01/12/2000EP0971034A1 Process for preparing antibody molecules
01/12/2000EP0971033A2 Test and model for Alzheimer's disease
01/12/2000EP0970377A1 Diagnosis of epithelial cell abnormalities
01/12/2000EP0970243A1 Diagnosis and treatment of glaucoma
01/12/2000EP0970236A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media
01/12/2000EP0970225A1 Improved metallo-endopeptidases
01/12/2000EP0970219A1 A porin gene from campylobacter jejuni, related products and uses thereof
01/12/2000EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
01/12/2000EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
01/12/2000EP0970215A1 Suppressor of cytokine signaling
01/12/2000EP0970212A1 Secreted salivary zsig32 polypeptides
01/12/2000EP0970208A1 Sp$g(a): A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO
01/12/2000EP0970207A1 Heregulin variants
01/12/2000EP0970205A2 Human endosulfine gene
01/12/2000EP0970187A1 Pituitary differentiation factor and methods of use thereof
01/12/2000EP0970185A1 Insecticidal protein toxins from $i(photorhabdus)
01/12/2000EP0970127A1 Antibody variants
01/12/2000EP0970125A2 Histidine decarboxylase immunoreactivity to detect cancer
01/12/2000EP0970122A1 Human anion channel
01/12/2000EP0970119A1 Synaptic activation protein compositions and method
01/12/2000EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus
01/12/2000EP0970112A2 Novel human cytokine/steroid receptor protein
01/12/2000EP0969876A2 Delivery system for gene therapy to the brain
01/12/2000EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
01/12/2000EP0725837B1 Adeno-associated virus - its diagnostic use with early abortion
01/12/2000EP0594764B1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor
01/12/2000EP0548234B1 Cloning of chicken anaemia dna
01/12/2000CN1241213A Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor
01/11/2000US6013782 Integrin-linked kinase and its uses
01/11/2000US6013781 Semaphorin gene family
01/11/2000US6013768 Kainate-binding human CNS receptors of the EAA1 family
01/11/2000US6013766 Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit
01/11/2000US6013631 Bactericidal/permeability-increasing protein (BPI) deletion analogs
01/11/2000US6013630 Using mutant atrial natriuretic factor proteins, fragments, analogs, derivatives and homologs thereof, the nucleic acids encoding these mutant proteins, and modulators of atrial natriuretic factor for treating or preventing ischemic stroke
01/11/2000US6013627 Organic compounds
01/11/2000US6013626 To inhibit the proliferation of mammalian cells; antitumor agents
01/11/2000US6013526 Modified protein for gene transfer and process for producing the same
01/11/2000US6013523 Plant cell comprising a pesticidal protein toxin encoded by a synthetic bacillus gene; for plant protection against insect damage; pesticides; insecticides
01/11/2000US6013521 Culture system used for the maintenance of neuronal tissues; for use in the treatment of neuronal disorders and detection of neuronal modulators
01/11/2000US6013519 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
01/11/2000US6013514 Nucleic acid sequence coding for a membrane protein; for treatment diagnosis, dectection, and prevention of infections
01/11/2000US6013508 Polynucleotide sequence which codes for a protein that confers antibiotic resistance; accurate detection and screening for the presence of gram-positive bacteria resistant to antibiotics,
01/11/2000US6013505 Polynucleotide sequence coding a polypeptide in vovolved in coiling deoxyribonucleic acids; for diagnosis and antibiotic development against bacterial infection
01/11/2000US6013501 Hippuricase gene
01/11/2000US6013497 Polynucleotide sequence that codes a polypeptide; bactericides
01/11/2000US6013489 Using a recombinant nucleic acid sequence encoding a polypeptide for degrading or modifying pectin or pectin containing vegetable or plant material; incubating pectin or plant material with degrading enzyme
01/11/2000US6013484 HIV-3 retrovirus and its use
01/11/2000US6013480 Antagonists of interleukin-15
01/11/2000US6013479 Human Emr1-like G protein coupled receptor
01/11/2000US6013478 Producing modified human polypeptides in cells; culturing cell transformed with a replicable expression vector containing modified nucleotide and amino acid sequences, recovering the expressed product polypeptide
01/11/2000US6013476 DNA encoding tumor necrosis related receptor TR7
01/11/2000US6013475 Nucleotide sequences coding a protein that binds to a receptor/ligand complex; for treatment of autoimmune diseases, graft rejection, and cancer
01/11/2000US6013474 Calcium channel compositions and methods
01/11/2000US6013473 Nucleic acid sequence encoding a deoxyribonucleic acid repair enzyme; for treatment, prevention, and diagnosing cancer; antitumor/anticarcinogenic agents
01/11/2000US6013471 DNA encoding hK2 variant polypeptides
01/11/2000US6013464 Human PAK65
01/11/2000US6013463 Diagnostic test kit for detecting campylobacter infection; for diagnosis of peptic ulcer disease or gastrointestinal cancer
01/11/2000US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions
01/11/2000US6013454 Kinesin-like motor protein
01/11/2000US6013452 Fungi such as aspergillus oryzae which do not produce proteases, useful as hosts for production of proteins susceptible to proteolytic degradation by proteases usually produced by the fungi
01/11/2000US6013450 CAF1-related protein
01/11/2000US6013267 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
01/11/2000US6013264 Comprising hepatitis b surface antigen (hbsag); stability, efficiency; for immunization against diphtheria, tetanus, pertussis, polio, haemophilus influenzae b, hepatitis a, meningitis a, meningitis b, meningitis c, and otitis media
01/11/2000US6013262 Recombinant papilloma virus L1
01/11/2000US6013258 Immunogenic peptides from the HPV E7 protein
01/11/2000US6013257 Neurotactin and uses therefor
01/06/2000WO2000000824A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
01/06/2000WO2000000634A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI)